# Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

> **NCT00489411** · PHASE3 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 231 (actual)

## Conditions studied

- Neurotoxicity
- Pain
- Peripheral Neuropathy
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** duloxetine hydrochloride
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00489411
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2012-01
- **Final completion:** 2013-03
- **Target enrollment:** 231 (ACTUAL)
- **Last updated:** 2017-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00489411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00489411, "Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00489411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*